Besides the therapeutical effects of several cannabinoids as antiemetics, analgesics, antispasmodics, appetite-stimulating, and sleeping inductors [12]; THC, a phytocannabinoid partial CB1 agonist, as well as WIN55,212–2, a synthetic CB1 agonist, have both been proved to have an anticonvulsant effect in vitro [13] and in rodent models [14] of epilepsy and status epilepticus, being more effective than conventional antiepileptics like phenytoin and phenobarbital [15]. This evidence concerns the gene CNR1 and epilepsy.